Natural products and their semi-synthetic derivatives against antimicrobial-resistant human pathogenic bacteria and fungi. 2022

Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar 190006, India.

Human infectious diseases caused by various microbial pathogens, in general, impact a large population of individuals every year. These microbial diseases that spread quickly remain to be a big issue in various health-related domains and to withstand the negative drug impacts, the antimicrobial-resistant pathogenic microbial organisms (pathogenic bacteria and pathogenic fungi) have developed a variety of resistance processes against many antimicrobial drug classes. During the COVID-19 outbreak, there seems to be an upsurge in drug and multidrug resistant-associated pathogenic microbial species. The preponderance of existing antimicrobials isn't completely effective, which limits their application in clinical settings. Several naturally occurring chemicals produced from bacteria, plants, animals, marine species, and other sources are now being studied for antimicrobial characteristics. These natural antimicrobial compounds extracted from different sources have been demonstrated to be effective against a variety of diseases, although plants remain the most abundant source. These compounds have shown promise in reducing the microbial diseases linked to the development of drug tolerance and resistance. This paper offers a detailed review of some of the most vital and promising natural compounds and their derivatives against various human infectious microbial organisms. The inhibitory action of different natural antimicrobial compounds, and their possible mechanism of antimicrobial action against a range of pathogenic fungal and bacterial organisms, is provided. The review will be useful in refining current antimicrobial (antifungal and antibacterial) medicines as well as establishing new treatment strategies to tackle the rising number of human bacterial and fungal-associated infections.

UI MeSH Term Description Entries

Related Publications

Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
January 2023, Molecules (Basel, Switzerland),
Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
January 2016, African journal of traditional, complementary, and alternative medicines : AJTCAM,
Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
October 2021, Molecules (Basel, Switzerland),
Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
January 2015, Applied and environmental microbiology,
Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
January 2020, ACS infectious diseases,
Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
November 2021, Biochemical Society transactions,
Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
August 2023, Applied microbiology and biotechnology,
Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
January 2020, World journal of microbiology & biotechnology,
Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
October 2016, Molecular pharmaceutics,
Hafsa Qadri, and Abdul Haseeb Shah, and Syed Mudasir Ahmad, and Bader Alshehri, and Abdullah Almilaibary, and Manzoor Ahmad Mir
August 2020, Molecules (Basel, Switzerland),
Copied contents to your clipboard!